New test spots kidney disease patients at high risk of failure
NCT ID NCT02199145
First seen Mar 27, 2026 · Last updated May 25, 2026 · Updated 7 times
Summary
This study looked at 52 adults with membranous nephropathy, an autoimmune kidney disease. Researchers tested a new blood test that measures specific antibodies to see if it could predict which patients would get worse and need dialysis. The goal was to confirm earlier findings that this test might help identify high-risk patients earlier.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MEMBRANOUS NEPHROPATHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AP-HM
Marseille, 13354, France
-
CHU de Besançon
Besançon, France
-
Nephrology Department, Nice University Hospital
Nice, 06003, France
Conditions
Explore the condition pages connected to this study.